Ventyx Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Ventyx Biosciences

10/08/2023 22:02

* Ventyx Biosciences Inc  VTYX.OQ  reported a quarterly
adjusted
loss of 91 cents​​ per share for the quarter ended in June. The
mean expectation of ten analysts for the quarter was for a loss
of 71 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Ventyx Biosciences Inc's reported EPS for the quarter was
a loss
of 91 cents​.
    * The mean earnings estimate of analysts had fallen by
about 4.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Ventyx Biosciences Inc shares had fallen by 0.1% this
quarter and held steady so far this year.
    * The company reported a quarterly loss of $53.25 million.
    * Wall Street's median 12-month price target for Ventyx
Biosciences Inc is $55.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.71          -0.91          Missed
 Mar. 31 2023      -0.65          -0.68          Missed
 Dec. 31 2022      -0.64          -0.62          Beat
 Sep. 30 2022      -0.44          -0.59          Missed